Asia AL-Naamani


Asia AL-Naamani Doctor of Medicine, MD in 2008, Master in Epidemiology and medical statistics 2013, Department of woman and child health, Ministry of health, Oman. Member of the national task force of reviewing cases of child abuse at the central level, Oman. Participated in orientation of health care providers involved in child abuse management to the health care providers and as speaker in conferences and workshops, Organizer of the national TOT trainer in child abuse management workshop. Participated in developing guidelines related to child health program such as Guideline for Medical Management of Children and Young People with Down syndrome, 2015,Medical Management of Children and Young People with Down syndrome, training modules, 2015,Clinical Guidelines on Child Abuse and Neglect, 2016,Management of Child Abuse and Neglect, training module, 2016,proposal on expansion of newborn screening and operational plan 2017,Health education materials for parents with children with Down syndrome,2018,Guidelines for the safe transportation of clinically ill children, 2019(in process),Guidelines for neonatal screening and management, congenital hypothyroidism, 2019(in process).Instructor of the research sessions for the residents as part of Oman Medical Specialty Board curriculum. Participated in national conferences and workshops. Recently I have been assigned as an organizer for ISPCAN International Congress, Oman 2019 and as organizer for first gulf autism conference, Oman 2020.



Short Description of the Lectures:

1. National screening program for autistic spectrum disorder and other developmental disorders

Improving the status of children’s health is recognized as fundamental for family, community and for the nation. There is a strong rationale for considering children as high priority groups for health improvement especially children with disability where Autistic Spectrum Disorder (ASD) and other developmental disorders are one of them. Autism Spectrum Disorder (ASD) are more prevalent that often stated. The overall prevalence rate of ASD in Oman estimated at 20.35 at 10,000 population (95% confidence interval [CI] 19.39-21.32) between 2012-2018. Screening tools available for clinicians and parents can now detect a reasonable proportion of children with ASD between (16-30 months). They consist of simple checklists completed by parents and followed-up by primary physicians. Since September 2016, Ministry of Health has established a national screening program for Autistic Spectrum Disorder (ASD) by using the M-CHAT/R & (M-CHAT-R/F). M-CHAT (Modified Checklist for Autism in Toddlers) is a validated developmental screening tool for toddlers between 16 and 30 months of age. The aim is to screen all children visiting the health institution for the routine well-baby visit at 18 months. Improving quality of life of children with Autism Spectrum Disorder (ASD) and other developmental disorders through early identification and management.